A A A

4. Mitteldeutsches Symposium

Neuroendokrine Tumoren

28. - 29. Juli 2013 | Goethe-Nationalmuseum Weimar

Wir haben für Sie die einzelnen Vorträge des Symposiums mitgeschnitten und möchten sie Ihnen an dieser Stelle in voller Länge präsentieren.

Prof. Dr. med. Richard P. Baum

Prof. Dr. med. Richard P. Baum

Begrüßung
Prof. Dr. med. Richard P. Baum
Zentralklinik Bad Berka

PD Dr. med. Gabriele Pöpperl

PD Dr. med. Gabriele Pöpperl

"Rational diagnostic strategy to define patients for PRRT by PET/CT"
PD Dr. med. Gabriele Pöpperl
Katharinenhospital – Klinikum Stuttgart

Harshad Kulkarni

Harshad Kulkarni

"Impact of standardized uptake values on PRRT outcome"
Harshad Kulkarni
Zentralklinik Bad Berka

PD Dr. med. Samer Ezziddin

PD Dr. med. Samer Ezziddin

"Impact of proliferation rate on therapeutic outcome of PRRT"
PD Dr. med. Samer Ezziddin
Universitätsklinikum Bonn

Dr. med. Alexander Haug

Dr. med. Alexander Haug

"PET/CT for the early prediction of response to PRRT in patients with well differentiated neuroendocrine tumors and comparison to MRI and CT"
Dr. med. Alexander Haug
Klinikum der Universität München

Prof. Harvey Turner

Prof. Harvey Turner

"Combination therapies"
Prof. Harvey Turner
Fremantle Hospital, Australia

Lisa Bodei MD PhD

Lisa Bodei MD PhD

"Dosimetry of PRRT patients – methodology and clinical relevance"
Lisa Bodei MD PhD
Radionuclide Therapy Section, Division of Nuclear Medicine Milano

Dr. med. Jaap Kwekkeboom MD PhD

Dr. med. Jaap Kwekkeboom MD PhD

"Neo-adjuvant PRRT"
Dr. med. Jaap Kwekkeboom MD PhD
Department of Gastroentrology and Hepatology Rotterdam

Dr. med. Thomas Pöppel

Dr. med. Thomas Pöppel

"PRRT according to European, IAEA and German guidelines"
Dr. med. Thomas Pöppel
Universitätsklinikum Essen

Dr. med. Vikas Prasad

Dr. med. Vikas Prasad

"How to best protect kidney and bone marrow function"
Dr. med. Vikas Prasad
Charité – Universitätsmedizin Berlin

Dr. med. Clemens Kratochwil

Dr. med. Clemens Kratochwil

"Intra-arterial PRRT: indication, technique and results"
Dr. med. Clemens Kratochwil
Universitätsklinikum Heidelberg

Prof. Dr. med. Richard P. Baum

Prof. Dr. med. Richard P. Baum

"DUO-PRRT –10 year analysis"
Prof. Dr. med. Richard P. Baum
Zentralklinik Bad Berka

Prof. Dr. med. Dieter Hörsch

Prof. Dr. med. Dieter Hörsch

"Effectiveness of PRRT in Germany: an analysis of 450 patients"
Prof. Dr. med. Dieter Hörsch
Zentralklinik Bad Berka

Dr. med. Marleen Melis

Dr. med. Marleen Melis

"New developments in preclinical and clinical application of PRRT"
Dr. med. Marleen Melis
Department of Nuclear Medicine Rotterdam

Prof. Dr. med. Irvin Modlin

Prof. Dr. med. Irvin Modlin

"New developments in basic science »From Goethe and Godel to G-phase«"
Prof. Dr. med. Irvin Modlin
Yale University School of Medicine

Univ.-Prof. Dr. med. Marianne Pavel


Univ.-Prof. Dr. med. Marianne Pavel


"Clinical relevance of ENETS guidelines 2012"
Univ.-Prof. Dr. med. Marianne Pavel
Charité Berlin

Prof. Dr. med. Andrea Frilling

Prof. Dr. med. Andrea Frilling

"Diagnosis and therapy of neuroendocrine liver metastases"
Prof. Dr. med. Andrea Frilling
Imperial College London

Prof. Dr. med. Detlef K. Bartsch

Prof. Dr. med. Detlef K. Bartsch

"Standards in surgical therapy of neuroendocrine neoplasias"
Prof. Dr. med. Detlef K. Bartsch
Universitätsklinikum Marburg

Prof. Dr. med. Hans Scherübl

Prof. Dr. med. Hans Scherübl

Dr. rer. pol. Okan Zaba

Dr. rer. pol. Okan Zaba

Dr. rer. pol. Okan Zaba

"Prognosis and characteristics of patients with neuroendocrine neoplasias oft the lung"
Dr. rer. pol. Okan Zaba
Evangelische Lungenklinik Berlin

Dr. med. Anja Rinke

Dr. med. Anja Rinke

"Final analysis of the german neuroendocrine tumor registry: what can we learn?"
Dr. med. Anja Rinke
Universität Marburg

Dr. med. Jonathan Strosberg

Dr. med. Jonathan Strosberg

"Chemotherapy in neuroendocrine neoplasias: Temozolomide/Capecitabine and beyond"
Dr. med. Jonathan Strosberg
H. Lee Moffitt Cancer Center & Research Ins Tampa